pharmaceuticals

Vertex Pharmaceuticals Q2 profit jumps 29%, beats estimates

July 31, 2019

ACADIA Pharmaceuticals Q2 results beat estimates, raises outlook

July 31, 2019

Amarin’s stock gains on Q2 results beat

July 31, 2019

Pfizer’s stock suffers as Q2 results and Mylan deal fail to impress Wall Street

July 30, 2019

Celgene Q2 profit beats estimates, lifts FY19 guidance

July 30, 2019

Merck rises on oncology strength post Q2 earnings

July 30, 2019

Eli Lilly Q2 profit beats estimates, lifts FY19 forecast

July 30, 2019

Earnings preview: What to look for when Gilead reports Q2 results

July 29, 2019

Sanofi slips to a loss in Q2 on Eloctate impairment charge

July 29, 2019

Earnings preview: A look at key factors affecting Pfizer’s Q2 results

July 26, 2019

Bristol-Myers Q2 earnings, revenue top Street; stock dips on weak guidance

July 25, 2019

AstraZeneca’s Q2 results beat market expectations

July 25, 2019

What to expect from AbbVie Q2 earnings

July 24, 2019

Earnings preview: Celgene deal in focus as Bristol-Myers prepares for Q2 results

July 24, 2019

Earnings: Alexion Pharma Q2 results top expectations; raises FY19 guidance

July 24, 2019

These deals set a new paradigm for healthcare industry

June 10, 2019

Looming opioid epidemic calls for stricter drug regulation

May 29, 2019

Novartis’ one-time gene therapy for spinal muscular atrophy gets FDA nod

May 24, 2019

Earnings preview: Amarin likely to deliver strong Q4 results

February 25, 2019

AbbVie slips to loss in Q4, misses estimates

January 25, 2019

Arrowhead Pharmaceuticals reports a loss of 12 cents per share in Q4

December 11, 2018